Department of Psychiatry & Behavioral Science, Northwestern University, Feinberg School of Medicine, USA.
|Funded by Dainippon Sumitomo Pharma Ltd, Reviva Pharmaceuticals, Naurex Pharmaceuticals, and Astellas: to conduct innovative research to unravel receptor mechanisms: 5-HT1A, 5-HT7, 5-HT2A, 5-HT2C, 5-HT6, alpha 7, GABAa, GABAb, D1, D2, receptors in mechanism of medicines for mental disorder like schizophrenia, bipolar disorder, depression, et al. (systemic, local drug administration/ behavioral/neuropathological analyses in C57BL/6 and genetically modified mice).|
|Neuropsychopharmacology, Neuropharmacology, Behavioral pharmacology, cognition, animal handling, experimental designs, Pharmacology of Preclinical, statistical analyses, and neuropathology|
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : December 10, 2017